Auricular fibrillation as a risk factor of cerebrovascular events in the over-65s. Is clinical practice in anticoagulant prophylaxis adequate?;Fibrilación auricular como factor de riesgo de acontecimientos cerebrovasculares en personas mayores de 65 años: ¿Es adecuada la práctica clínica en profilaxis anticoagulante?

Atencion Primaria

Volumn 36, Issue 4, 2005, Pages 198-203

  Gayoso Diz, Pilar ^a   Calle Custodio, R ^b   Prieto Maroto, A ^b   Herrera Calvo, D ^b   Sala Lopez A I ^b   Gomez Mosquera M D ^b  

^a Unidad de Investigacion   (Spain)

^b CSA Carballeira   (Spain)

Author keywords

Antithrombotic therapy; Atrial fibrillation; Elderly; Stroke prevention

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGE; AGED; ANAMNESIS; ANTICOAGULATION; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL PRACTICE; DEMOGRAPHY; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; RISK FACTOR;

EID: 27144454876     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13078612     Document Type: Article

References (20)

1. Kannel WB, Abbot RD, Savage DD, McNamara PM. Epidemiological features of chronic atrial fibrillation: the Framingham Study. N Engl J Med. 1982;306:1018-22.
2. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns FA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiology. 1991;18:349-55.
3. Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Stroke prevention in non valvular atrial fibrilation. Ann Intern Med. 1991;115:727-36.
4. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271:840-4.
5. Wolf PA, Abbot RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-8.
6. a ed. Barcelona: Harcourt-Brace; 1999. p. 1210-21.
7. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from the randomised controlled trials. Arch Intern Med. 1994;154:1449-57.
8. Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Intern Med. 1999;131:492-501.
9. Segal JB, McNamara RL, Miller MR, et al. Prevention of thromboembolism in atrial fibrillation: a meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med. 2000;15:56-67.
10. Albers GW, Dalen JE, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Chest. 2001;119 Suppl:194-206.
11. Fuentes López E, Martín F, Salgado Ordóñez A, Sánchez Silvestre F, Martos Crespo, González Correa JA. Valoración del tratamiento antitrombótico en pacientes con fibrilación auricular crónica no valvular. Aten Primaria. 1998;22:172-5.
12. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. 2000;160:41-6.
13. Córdoba R, Hernández AC. Fibrilación auricular en el anciano. FMC. 1999;6:240-8.
14. Brotons C, Moral I, Antón JJ, et al. Tratamiento preventivo de la fibrilación auricular no reumática: de la eficacia de los ensayos clínicos a la efectividad en la práctica clínica. Aten Primaria. 1997;20:367-71.
15. American Geriatrics Society. The use of oral anticoagulants (warfarin) in older people. J Am Geriatr Soc. 2002;50:1439-45.
16. Fahey T, Rimmer J, Godfrey P. Risk stratification in the management of atrial fibrillation in the community. Br J Gen Pract. 1999;49:295-6.
17. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ. 2000;320:1380-4.
18. Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med. 1996;156:1829-36.
19. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke. 1994;25:1721-5.
20. Devereaux P, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ. 2001;323:1218-22.